Understanding type 1 diabetes with AI and glucose data
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study uses artificial intelligence to analyze glucose monitor data from people with type 1 diabetes. The goal is to find patterns that could improve care and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have type 1 diabetes.
- You use a continuous glucose monitor (CGM) and have been using it for at least the last 6 months of 2024.
- You are seen regularly at the Endocrinology and Nutrition Department of Hospital de la Santa Creu i Sant Pau.
- You are willing to sign a consent form to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an artificial intelligence (AI) system can help manage insulin pump therapy remotely for people with type 1 diabetes. The goal is to improve blood sugar control and make diabetes management easier.
This trial tests a new continuous glucose monitor (a small sensor that checks blood sugar levels) to see how well and safely it works in people with type 1 diabetes. You'll wear the sensor for 15 days and attend three clinic visits to check its accuracy against blood samples.
This study tests a new wearable sensor to see if it can help people with type 1 diabetes better track their blood sugar levels. It might lead to easier and more accurate glucose monitoring.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests an artificial intelligence feature that helps the insulin pump deliver extra insulin before meals. It aims to improve blood sugar control for adults with type 1 diabetes who already use an automated insulin delivery system.
This study uses a small device to record your heart's electrical activity (ECG) and artificial intelligence to see if it can track your blood sugar levels without finger pricks. If it works, it could make managing type 1 diabetes easier.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.